HSINCHU, Aug. 8, 2022 /PRNewswire/ — NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from the local government of the Ministry of Health and Welfare in Taiwan in July 2022 and is planned for submission to the FDA (U.S. Food and Drug Administration) for clearance by the end of 2022.

Taiwan approves the First Autonomous Neurosurgical Navigation Robot, NaoTrac, from Brain Navi Biotechnology comes via ChinaTechNews.com.